Eurofins Discovery: Use of BioMAP Platform to Assess Nutrace

ST. CHARLES, Mo., June 23, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery

Related Keywords

Claude Huriez , Sibelius Ltd , University Of Buckingham , Bioscience Research , Phenotypic Center , Nuclear Hormone Receptors , Institute For Biomedical , Euronext Paris Stock Exchange , European Genomic Institute For Diabetes , Phenotypic Profiling , Screening Platform , European Genomic Institute , Hospital Claude Huriez , Eurofins Discovery , Ion Channels , Euronext Paris Stock , Eurofins , Discovery , Iomap , Platform , Ssess , Nutraceuticals , Published , Abiomed , Central ,